These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7588006)

  • 21. Percutaneous Irreversible Electroporation for Pancreatic VIPoma: A Case Report.
    Niu L; Li J; Zeng J; Fang G; Zhou L; Xu K; Zhang K
    Pancreas; 2017 Jan; 46(1):135-137. PubMed ID: 27977628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
    Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
    Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A vasoactive-intestinal-polypeptide producing tumor (VIPoma) as an uncommon cause of life-threatening hypokalemia].
    Mráz L; Rusavý Z; Zdenĕk P; Heidenreichová M; Kozeluhová J; Steinigerová J; Tĕsínský P
    Vnitr Lek; 1995 Aug; 41(8):535-7. PubMed ID: 7483336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [W.D.H.A. Syndrome due to occult neuroendocrine malignancy with concomitant liver metastases].
    Rammer M; Kirchgatterer A; Höbling W; Stockhammer M; Knoflach P
    Z Gastroenterol; 2003 Feb; 41(2):185-9. PubMed ID: 12592602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The coexistence of 2 different neuroendocrine tumors of the upper gastrointestinal tract and pancreas].
    Reusch J; Keck AM; Link KH; Mohr HH
    Dtsch Med Wochenschr; 1998 Dec; 123(49):1472-7. PubMed ID: 9861888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of metastatic Vipoma by liver transplantation.
    Bramley PN; Lodge JP; Losowsky MS; Giles GR
    Clin Transplant; 1990 Oct; 4(5 part 1):276-8; discussion 279. PubMed ID: 10150088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vipoma of the pancreas complicating ulcerative colitis.
    Yanagi H; Kusunoki M; Sakanoue Y; Shoji Y; Yamamura T; Murai M; Kikkawa N; Utsunomiya J
    Am J Gastroenterol; 1991 Aug; 86(8):1066-9. PubMed ID: 1650130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
    Bouin M; Aoust LD
    Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
    Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
    JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Paralytic ileus as an initial manifestation of malignant VIPoma of the pancreas--case report with review of the literature].
    Koberstein B; Eysselein VE; Balzer K; Müller MK; Eberlein G; Singer MV; Willemer S; Adler G; Goebell H
    Z Gastroenterol; 1990 Jun; 28(6):295-301. PubMed ID: 1978446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vipoma. 9-year observations using currently available therapy methods].
    Zimmermann K; Rapp T; Binder J; Frölich J; Bode JC
    Dtsch Med Wochenschr; 1986 Feb; 111(8):298-301. PubMed ID: 2868874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors.
    Song S; Shi R; Li B; Liu Y
    Pancreas; 2009 Oct; 38(7):811-4. PubMed ID: 19657309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
    Christensen C
    Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
    Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
    J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995).
    Niitsu Y; Goto Y; Maeda M; Tsushima N; Watanabe N; Kohgo Y; Urushizaki I
    Aliment Pharmacol Ther; 1988 Jun; 2(3):269-79. PubMed ID: 2856504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
    Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
    Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amelioration of symptoms and reduction of VIP levels after hepatic artery chemoembolization in a patient with sandostatin resistant VIPoma.
    Shaib W; Mitchell K; Saif MW
    Yale J Biol Med; 2010 Mar; 83(1):27-33. PubMed ID: 20351979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression of a large malignant gastrinoma on treatment with Sandostatin LAR: a case report.
    Granberg D; Jacobsson H; Oberg K; Gustavsson J; Lehtihet M
    Digestion; 2008; 77(2):92-5. PubMed ID: 18376130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.